...
首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >The analysis of estrone and 17 beta-estradiol by stir bar sorptive extraction-thermal desorption-gas chromatography/mass spectrometry: Application to urine samples after oral administration of conjugated equine estrogens
【24h】

The analysis of estrone and 17 beta-estradiol by stir bar sorptive extraction-thermal desorption-gas chromatography/mass spectrometry: Application to urine samples after oral administration of conjugated equine estrogens

机译:搅拌棒吸附萃取-热脱附-气相色谱/质谱法分析雌酮和17β-雌二醇:口服共轭马雌激素后在尿液样品中的应用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The development of a sensitive and solvent-free method for the measurement of estrone (E-1) and 17 beta-estradiol (17 beta-E-2) in human urine samples is described. The deconjugated estrogens were derivatized in situ with acetic acid anhydride and the derivatives were extracted directly from the aqueous samples using stir bar sorptive extraction (SBSE). The compounds containing a secondary alcohol function are further derivatized by headspace acylation prior to thermal desorption and gas chromatography/mass spectrometry (GC/MS). A number of experimental parameters, including salt addition, temperature and time, were optimized to increase the recovery of E, and 17 beta-E-2 by SBSE. The derivatization reactions were also optimized to obtain the highest yields of the acylated estrogens. Detection limits of 0.02 and 0.03 ng mL(-1) were obtained for E, and 17 beta-E-2, respectively. The method was applied to determine the effect of conjugated equine estrogen intake on the excretion of E, and 17 beta-E-2 in human urine samples. Increased levels of the endogenous estrogens were detected after administering a standard dose of Premarin to a female volunteer. Routine monitoring of estrogen levels is recommended to avoid a high urinary excretion of El and 17 beta-E-2, nowadays enlisted as endocrine disrupting chemicals (EDCs), during hormone replacement therapy. (C) 2007 Elsevier B.V. All rights reserved.
机译:描述了一种用于测定人尿液样品中雌酮(E-1)和17β-雌二醇(17 beta-E-2)的灵敏且无溶剂的方法的开发。解离的雌激素用乙酸酐原位衍生,并使用搅拌棒吸附萃取(SBSE)从含水样品中直接萃取衍生物。在热脱附和气相色谱/质谱(GC / MS)之前,通过顶空酰化作用进一步衍生含有仲醇功能的化合物。优化了包括盐添加,温度和时间在内的许多实验参数,以提高SBSE对E和17 beta-E-2的回收率。还优化了衍生化反应以获得最高产率的酰化雌激素。对E和17个​​beta-E-2的检出限分别为0.02和0.03 ng mL(-1)。该方法用于确定摄入马雌激素对人尿液中E和17β-E-2的排泄的影响。在向女性志愿者施用标准剂量的普力马后,检测到内源性雌激素水平升高。建议常规监测雌激素水平,以免在激素替代疗法期间,El和17 beta-E-2(现今被列为内分泌干扰化学物质(EDC))的高尿排泄。 (C)2007 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号